Pilot Study of the Effects of GC811007 Administration on Copper and Trace Metal Metabolism in Non-diabetic Subjects and Patients with Type 2 Diabetes Mellitus: a randomized, double-blind, placebo-controlled trial in adult males with Type 2 diabetes mellitus and non-diabetic subjects to measure the effects on urinary copper, zinc and iron excretion.
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Trientine (Primary)
- Indications Diabetic cardiomyopathy
- Focus Pharmacodynamics
- 28 May 2013 New trial record